PATENT CLAIM ANALYSIS

Application Number: 15756500
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "078170"]

Abstract:
Disclosed is a hemostatic material, wherein a thrombin receptor activating agent is covalently coupled to a biocompatible matrix.

Claim (Index 13):
A kit, preferably for use in surgery and/or in the treatment of injuries and/or wounds, comprising\n a hemostatic material according to  claim 1  and at least one administration device, preferably selected from the group buffer solution, especially a buffer solution containing Ca 2+  ions, a syringe, a tube, a catheter, forceps, scissors, a sterilising pad or lotion.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.17647
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14460353', '13173013', '14836014', '13758942', '10251703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7092659871381423
- 35 USC 102 Novelty (BERT): 0.5057397491230039
- Combined Prediction Score: 0.6889133633366284
- Mean Citation Score: 216.677474
- Max Citation Score: 227.17107
- Similarity Product: 137.53806461863695

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test